Organic and Inorganic Iodine Forms. Supplementation and Excessive Intake of This Constituent

Many individuals mistakenly associate the term "organic iodine" with safe, natural food products, whereas in reality it refers to hazardous radioactive isotopes such as iodine-129 and iodine-131, which are generated through nuclear fission processes. These radioactive forms of iodine pose a significant health risk, particularly to the thyroid gland, where they can accumulate and induce lasting damage. Contrary to common perception, the term "organic" in this context bears no relation to organic farming, and its use in supplement marketing is deceptive and potentially harmful to consumers.

Inorganic iodine, referred to as elemental iodine, exists in the natural environment both in its free state and in chemically bound forms. As a trace element, it plays a pivotal role in human physiology, serving as an indispensable component of thyroid hormones—thyroxine (T4) and triiodothyronine (T3). These hormones govern critical biochemical processes, including protein synthesis, enzymatic activity, and the development of the skeletal system and central nervous system, particularly during prenatal and early childhood stages. Since iodine is not stored in significant quantities within bodily tissues, its continuous replenishment through dietary intake or supplementation is essential for maintaining metabolic equilibrium. In coastal regions, atmospheric elemental iodine can be absorbed by the human body via inhalation, the gastrointestinal tract, and transdermal penetration. Prolonged deficiency of this trace element may result in pathological alterations in the thyroid gland, such as the hyperplasia of glandular epithelium, commonly known as goiter [1].

The recommended daily allowance of iodine for adults is established at 150 micrograms, a guideline supported by authoritative bodies such as the American Institute of Medicine, the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), and the International Council for the Control of Iodine Deficiency Disorders (ICCIDD). These organizations have further defined an upper tolerable intake level—representing an approximate threshold below which significant adverse effects are unlikely in a healthy population—at 1100 micrograms per day. While iodine intake exceeding 150 μg is generally well tolerated by most individuals, certain vulnerable subgroups—including those with preexisting thyroid conditions, the elderly, neonates, and individuals with genetic predispositions or other risk factors—may experience iodine-induced thyroid dysfunction. Research conducted on both animal and human models indicates that elevated iodine consumption may increase the incidence of autoimmune thyroiditis. Additionally, some studies suggest a potential association between iodine supplementation and an elevated risk of papillary thyroid carcinoma. Dietary sources of iodine include marine fish, egg yolks, dairy products, beef, cereal grains, fruits, and vegetables, as well as iodized table salt. However, the highest concentrations of iodine are found in pharmaceutical preparations, dietary supplements, and radiographic contrast agents, where levels can exceed dietary amounts by several orders of magnitude.

Over the course of the past century, systematic iodine supplementation has emerged as a cornerstone of global public health initiatives aimed at eradicating iodine deficiency—the primary cause of preventable intellectual impairment worldwide. Iodine has been administered through multiple delivery mechanisms, including intravenous and intramuscular injections, incorporation into drinking water supplies, utilization in agricultural irrigation systems, enrichment of livestock feed, and—most ubiquitously—through the iodization of table salt and other food products. These interventions have yielded measurable success in reducing the prevalence of iodine deficiency and its associated health consequences, particularly over the last several decades.

However, the increased availability of iodine has also raised concerns regarding the potential adverse effects of excessive intake. The U.S. National Research Council has established the recommended daily allowance at 150 micrograms for the general population, with an additional 25 µg/day advised for pregnant women and 50 µg/day during lactation. Clinical evidence, however, indicates that uncontrolled consumption of iodine supplements—particularly in tablet form—can lead to severe thyroid dysfunction. This is corroborated by documented cases of congenital hypothyroidism in newborns whose mothers ingested excessive iodine during pregnancy, as well as thyroid dysfunction in infants born to mothers who consumed high quantities of iodine-rich seaweed during gestation and breastfeeding.

In response to these findings, the American Thyroid Association has issued formal guidelines stipulating that iodine supplements should not exceed 500 µg per day unless specific medical indications justify higher doses. Iodine exists in both organic and inorganic forms in nature. Dietary sources include marine fish, dairy products, and meat, while artificial sources comprise iodized salt and specialized supplements. It is critical to emphasize that both deficiency and excess iodine can result in significant thyroid dysfunction. Therefore, supplementation must be closely monitored, particularly in pregnant and breastfeeding women, to mitigate potential risks.